Chemotherapy Adherence Is a Favorable Prognostic Factor for Elderly Patients With Multiple Myeloma Who Are Treated With a Frontline Bortezomib-Containing Regimen

Yeungnam University Journal of Medicine
doi 10.12701/yujm.2018.35.1.76
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Yeungnam University College of Medicine

Related search

Efficacy and Safety of Reduced-Intensity Induction Therapy With a Bortezomib-Based Regimen in Elderly Patients With Multiple Myeloma

Therapeutic Advances in Hematology
Hematology
2012English

1p21 Deletions Are Strongly Associated With 1q21 Gains and Are an Independent Adverse Prognostic Factor for the Outcome of High-Dose Chemotherapy in Patients With Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2010English

Bortezomib Overcomes the Negative Prognostic Impact of Renal Impairment in a Newly Diagnosed Elderly Patient With Multiple Myeloma: A Case Report

Oncology Letters
Cancer ResearchOncology
2017English

Phase II Study of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy

British Journal of Haematology
Hematology
2017English

Chromosome 1 Abnormalities in Elderly Patients With Newly Diagnosed Multiple Myeloma Treated With Novel Therapies

Haematologica
Hematology
2014English

Bortezomib for the Treatment of Multiple Myeloma Patients

Health Technology Assessment
MedicineHealth Policy
2009English

Patients With Breast Cancer Who Are Treated With Chemotherapy Risk Long-Term Nerve Damage

Cancer
Cancer ResearchOncology
2018English

Managing Neutropenia by Pegfilgrastim in Patients Affected by Relapsed/Refractory Multiple Myeloma Treated With Bendamustine-Bortezomib-Dexamethasone

Supportive Care in Cancer
Oncology
2016English

Indirect Treatment Comparison of Cabazitaxel for Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Been Previously Treated With a Docetaxel-Containing Regimen

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy